查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853309

病毒學檢體採集市場​​：依技術、檢體類型、最終用戶、疾病類型及通路分類－2025 - 2032年全球預測

Virology Specimen Collection Market by Technology, Sample Type, End User, Disease Type, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，病毒學檢體體採集市場​​將成長至 193.2 億美元，複合年成長率為 24.63%。

關鍵市場統計數據
基準年2024年 33.1億美元
預計年份：2025年 41.3億美元
預測年份 2032 193.2億美元
複合年成長率（%） 24.63%

權威地闡述影響醫療保健系統中現代病毒學檢體檢體實務的技術、臨床和操作促進因素

病毒學檢體採集系統支撐著診斷的準確性、檢體的嚴謹性和公共衛生應對力。本導言概述了影響檢體採集實務的核心要素，涵蓋技術方法、檢體類型、臨床路徑以及依賴檢體完整性的最終使用者。在不斷變化的法規和對快速可靠診斷日益成長的需求的推動下，檢體採集方案如今已成為實驗室能力、供應鏈韌性和臨床工作流程三者交匯的關鍵環節。

本節概述了實驗室和醫療機構在採集病毒學檢體時面臨的關鍵操作考量。它重點強調了分析前變數的重要性，從採集設備的選擇到儲存條件，以及這些因素如何影響下游檢測的性能。此外，本節也將檢體採集置於更廣泛的系統層面促進因素中，例如對感染監測、治療監測和照護現場服務日益成長的需求。

讀完本導言，讀者將對影響檢體採集實務的技術、物流和相關人員因素有清楚的了解。這項基礎為後續章節中對技術模式、檢體類型、終端用戶動態、疾病重點領域和分發考慮的深入分析奠定了基礎。

快速的技術進步、供應鏈現代化和監管調整如何重塑檢體採集流程和臨床檢測預期

過去幾年，檢體採集領域發生了翻天覆地的變化，包括技術創新、營運流程重組和監管調整。新的檢測方法和檢體穩定化技術降低了分析前變異性，並實現了檢測的廣泛分散。同時，工作流程自動化和數位化樣本追蹤加強了樣本採集與結果交付之間的聯繫，提高了可追溯性並縮短了周轉時間。這些變化重新定義了人們對檢體品質和可用性的預期。

同時，快速診斷技術的興起和分子序列測定的擴展改變了所需檢體的類型以及檢體收集和儲存的要求。即時檢測環境現在需要堅固耐用、易於使用且相容於多種檢測方法的採集設備。因此，製造商和實驗室優先考慮以使用者為中心的設計和互通性。監管機構也透過明確生物樣本處理指南來回應，促進臨床和研究環境中的標準化。

綜合來看，這些變化帶來了新的機會和壓力：機會在於將檢測範圍擴大到服務不足的地區，並將診斷納入常規護理路徑；壓力在於對供應鏈、員工培訓和品質系統進行現代化改造，以滿足人們對主導檢體的決策日益成長的期望。

近期關稅政策的變化如何促使檢體採集供應鏈進行策略採購調整、供應商多元化和營運保障措施？

2025年關稅政策的變化為檢體採集耗材、儀器和輔助設備的籌資策略引入了新的變數。這些變化透過改變到岸成本和調整國內外供應商之間的比較優勢，影響了診斷試劑生產商、實驗室和經銷商的採購成本核算。為此，採購團隊審查了供應商多元化、庫存緩衝和近岸外包等方案，以維持供應的連續性和價格競爭力。

關稅波動對商業計劃的累積影響是多方面的。實驗室重新評估契約，將關稅相關條款納入其中，並提高訂購彈性。製造商考慮其他零件供應商，並在條件允許的情況下實施本地組裝，以減輕關稅波動的影響。經銷商調整定價框架和付款條件，以因應供應鏈複雜性的增加，同時與客戶合作最佳化訂單排序，減少缺貨。在整個生態系統中，相關人員重視情境規劃，以了解關稅波動將如何影響前置作業時間和產品供應情況。

重要的是，這些調整優先考慮了維持檢測可靠性和檢體完整性。各機構在更換供應商和材料時採用了更嚴格的驗證通訊協定，並增加對供應商品品管的投入，以確保關稅壓力帶來的變化不會影響臨床或研究結果。總體而言，這些因應措施表明，政策變化如何影響檢體採集的技術、商業性和合規等各個方面。

從全面、細分的觀點，分析技術模式、檢體類型、最終用戶、目標疾病和分銷管道如何驅動業務優先事項。

深入的市場細分揭示了不同技術、檢體類型、最終用戶、疾病關注點和分銷管道如何相互作用，從而定義檢體收集領域中不同的需求和機會。依技術分析，CLIA 和 ELISA 等免疫檢測對檢體量和處理條件有特定要求，而包括數位 PCR 和即時PCR在內的 PCR 方法則需要嚴格的核酸儲存和污染控制。快速檢測，無論是比色法還是側向層析法，都強調樣本採集的便捷性和快速穩定性，而像次世代定序和 Sanger定序這樣的測序方法則需要高品質的核酸提取和嚴格的監管鏈。

對樣本類型的分析揭示了血液、拭子、組織和尿液樣本不同的處理流程。拭子亞型，包括口腔拭子、鼻拭子和咽拭子，每種拭子都有不同的採集部位操作規程和運輸介質需求；而組織樣本，例如福馬林固定組織和新鮮冷凍組織，則需要不同的儲存方法和處理時間。臨床和參考實驗室需要標準化、高通量的樣本採集流程；公立和私立醫院需要在臨床吞吐量和患者舒適度之間取得平衡；診所和現場檢測點優先考慮便攜性和便利性；而學術和政府研究機構通常需要針對新型檢測方法制定專門的通訊協定。

以疾病為導向的細分市場強調病原體特有的細微差別。例如，肝炎病毒變種、愛滋病毒、甲型和乙型流感病毒以及SARS-CoV-2病毒，各自都有其獨特的採樣窗口、生物安全預防措施和穩定性考量。此外，分銷通路細分市場區分了直銷、經銷商網路和線上平台。本地和全國性經銷商影響物流和前置作業時間，而企業網站和第三方電商平台則重塑採購行為和需求預測。整合這些層面的資訊，有助於相關人員根據自身營運相關的技術和環境要求，調整產品設計、培訓和供應策略。

美洲、歐洲、中東和非洲以及亞太地區的區域動態和基礎設施現狀

區域動態影響全球衛生系統檢體採集的運作現況與策略重點。在美洲，已建立的實驗室網路和完善的公共衛生基礎設施促使人們投資於高通量採集途徑、與集中式診斷平台的整合以及自動化，以支援廣泛的監測和臨床檢測。該區域南北差異促使人們採用混合模式，將集中式採集能力與移動採集策略相結合，以涵蓋偏遠和醫療資源匱乏的社區。

在歐洲、中東和非洲，監管差異和基礎設施不均導致檢體採集實踐呈現出多元化的特點，而這些特點強調適應性。中東和非洲部分地區優先考慮能力建設、低溫運輸韌性以及能夠在資源受限的環境下可靠運作的分散式解決方案。這些區域差異促使各地在設備設計、人員編制模式和培訓項目方面採取不同的方法。

亞太地區擁有多元化的醫療保健生態系統，從已開發國家高度集中的檢測系統到新興市場蓬勃發展的即時檢測網路，不一而足。該地區兼具強大的製造能力和創新動力，催生了新型採集設備和可擴展的分銷模式。這些區域特徵共同影響採購偏好、檢驗要求以及新型檢體採集方法的採用速度。

市場領導如何將產品創新、策略夥伴關係和供應鏈韌性結合，以建立端到端的檢體採集解決方案和客戶支援模式

主要企業在製定產品標準、推動設備設計創新以及塑造檢體採集通路發揮著舉足輕重的作用。市場領導企業正大力投資研發，以改進檢體穩定化化學方法、提升採集設備的人體工學設計以及增強不同檢測平台之間的兼容性。這些公司也致力於建立完善的品質系統和法規專業知識，以支持跨境商業化並加速臨床實驗室和即時檢測機構的採用。

除了創新之外，策略夥伴關係和一體化服務模式正逐漸成為成功企業的標誌性特徵。檢測方法開發商、診斷實驗室和物流供應商之間的合作，能夠提供端到端的解決方案，從而降低推廣門檻，並確保檢體以可直接用於檢測的狀態送達。此外，投資於培訓和客戶支援的企業，能夠幫助終端用戶實施標準化的採集通訊協定，最大限度地減少分析前誤差，從而實現顯著的差異化優勢。

競爭地位日益取決於供應鏈的韌性以及提供滿足不同終端用戶需求的模組化解決方案的能力。那些既能兼顧產品廣度，又能集中投資於高影響力技術，並提供靈活銷售方案的公司，往往能夠獲得醫療系統、研究機構和商業實驗室的持續支持。

為產業領導者提供切實可行的策略藍圖，以協調設備創新、供應鏈韌性、監管參與和客戶能力，從而成功完成檢體採集。

產業領導者應採取整合策略，將產品創新與營運執行、監管前瞻性和供應鏈穩健性結合。優先考慮模組化儀器設計和跨檢測相容性，可實現快速的臨床和照護現場部署，並隨著檢測方法和測試平台的不斷發展，降低驗證負擔。以使用者為中心的包裝、清晰的標籤和培訓材料的配對投資，將提高樣本收集的準確性，減少分析前誤差，並最終帶來更好的後續結果。

在營運層面，各機構應實現供應商網路多元化，並考慮本地化生產或組裝，以降低關稅和物流風險，並維持品質監管。加強供應商資質資格確認流程並實施變更控制通訊協定，可確保材料替代不會影響檢體完整性。同時，企業領導者必須積極與監管機構溝通，預判檢體處理指南的變化，並簡化新採集設備的核准。

最後，企業應拓展合作模式，將設備與培訓、數位化檢體追蹤和物流服務捆綁在一起。透過提供整合解決方案，減輕實驗室和診所的實施負擔，企業可以加速技術應用，建立更牢固的客戶關係，並支持依賴可靠檢體採集的公共衛生舉措。

嚴謹的混合方法研究途徑，結合了相關人員訪談、技術文獻綜述和供應商檢驗，確保了對檢體收集實踐的可靠洞察。

本調查方法結合了定性和定量方法，對檢體採集流程和市場動態進行了嚴謹的分析。主要研究包括對實驗室主任、採購人員、臨床醫生和設備開發人員進行結構化訪談，以了解營運方面的見解和檢驗遇到的挑戰。次要研究則整合了監管指南、技術標準和同行評審文獻，以鞏固主要研究的發現並檢驗觀察到的趨勢。

資料收集著重於跨資訊來源的一致性和三角驗證，以識別因地區、最終用戶和技術而異的實踐。案例研究和供應商實質審查評估為供應鏈行為和產品檢驗選擇提供了實際背景。此外，訪談記錄的主題分析突顯了反覆出現的痛點，包括分析前變異性、低溫運輸限制和訓練缺口。

最後，研究結果經過內部同儕審查和調查方法檢驗，以確保其可靠性。這包括將程序描述與已發布的專業技術標準交叉比對，並在出現複雜或相互矛盾的資訊時向專家尋求澄清。總體而言，該方法兼顧了領域層面的細微差別和系統檢驗，從而為可操作的建議提供基礎。

一份全面的結論總結，重點強調了綜合檢體採集實踐、相關人員合作以及為保持診斷信心和公共衛生影響而採取的營運重點。

總之，檢體體採集對於診斷準確性、研究有效性和公共衛生應對至關重要。技術進步、法規演變和區域基礎設施差異已全面重塑了檢體的採集、儲存和運輸方式。相關人員，最能提供可靠的、主導檢體的檢測結果。

本文所展示的整合凸顯了整合解決方案的必要性，這些解決方案能夠減少分析前變異性，並支援在臨床、照護現場和研究環境中進行可擴展的檢測。透過專注於互通性、培訓和分發靈活性，各機構可以降低營運風險，並提高其診斷和監測計畫的有效性。展望未來，設備製造商、實驗室、醫療服務提供者和政策制定者之間需要持續合作，以確保檢體採集實踐與診斷創新同步發展。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 整合機器人樣本處理平台可提高病毒檢體採集的通量並降低污染風險。
  • 推出一款可攜式即時檢測PCR分析儀，用於在照護端分散檢測流感和SARS-CoV-2
  • 引入遠端醫療指導的自採集鼻拭子試劑套件，以擴大遠距病毒檢測服務的覆蓋範圍。
  • 開發一種溫度穩定的病毒轉運培養基配方，可延長保存期限並最大限度地減少對低溫運輸的依賴。
  • 新興的乾泡沫拭子技術可用於資源匱乏地區呼吸道病毒檢體的常溫儲存和運輸
  • 在病毒學實驗室中實施基於區塊鏈的數位樣本追蹤系統，以加強監管鏈完整性和資料安全性
  • 擴大高通量自動化核酸萃取設備的生產規模，以滿足呼吸道病毒爆發期間的需求激增
  • 將多重分子檢測板整合到常規檢測通訊協定中，推動了標準化檢體採集工作流程的需求。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按技術分類的病毒學檢體體採集市場

  • 免疫檢測
    • CLIA
    • ELISA
  • PCR
    • 數位PCR
    • 即時PCR
  • 快速檢測
    • 比色測試
    • 側向流
  • 定序
    • 次世代定序
    • 桑格定序

9. 依樣本類型分類的病毒學檢檢體採集市場

  • 血
  • 棉花棒
    • 口腔拭子
    • 鼻拭子
    • 咽拭子
  • 組織
    • 福馬林固定組織
    • 新鮮冷凍組織
  • 尿

第10章 依最終使用者分類的病毒學檢體採集市場

  • 診斷實驗室
    • 臨床實驗室
    • 參考實驗室
  • 醫院
    • 私立醫院
    • 公立醫院
  • 照護現場
    • 診所
    • 現場測試場地
  • 研究機構
    • 學術機構
    • 政府機構

第11章 依疾病類型分類的病毒學檢檢體採集市場

  • 肝炎
    • 甲型肝炎
    • B型肝炎
    • C型肝炎
  • HIV
  • 流感
    • 甲型流感
    • 乙型流感
  • SARS-CoV-2

第12章 病毒學檢檢體採集市場​​（依通路分類）

  • 直銷
  • 經銷商
    • 當地經銷商
    • 全國經銷商
  • 線上管道
    • 公司網站
    • 第三方電子商務

13. 各地區病毒學檢體體採集市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 病毒學檢體採集市場​​（依檢體分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國病毒學檢體體採集市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • Becton, Dickinson and Company
    • Copan Diagnostics, Inc.
    • bioMerieux SA
    • QIAGEN NV
    • Puritan Medical Products Company LLC
    • Sarstedt AG & Co. KG
    • Greiner Bio-One International GmbH
    • Merck KGaA
    • Cardinal Health, Inc.
Product Code: MRR-8201ABF20F0B

The Virology Specimen Collection Market is projected to grow by USD 19.32 billion at a CAGR of 24.63% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.31 billion
Estimated Year [2025] USD 4.13 billion
Forecast Year [2032] USD 19.32 billion
CAGR (%) 24.63%

An authoritative orientation to the technical, clinical, and operational drivers shaping modern virology specimen collection practices in healthcare systems

The landscape of virology specimen collection underpins diagnostic accuracy, research fidelity, and public health responsiveness. This introduction frames the core elements that influence specimen collection practices, encompassing technological approaches, specimen types, clinical pathways, and the end users that rely on robust sample integrity. Against a backdrop of regulatory evolution and heightened demand for rapid, reliable diagnostics, specimen collection protocols now sit at the intersection of laboratory capability, supply chain resilience, and clinical workflows.

This section outlines the major operational considerations that laboratories and healthcare providers face when collecting virology specimens. It emphasizes the importance of pre-analytical variables - from collection device selection to storage conditions - and highlights how these factors cascade into downstream assay performance. In addition, the introduction situates specimen collection within broader system-level drivers, including infection surveillance, therapeutic monitoring, and the scaling needs of point-of-care services.

By the end of this introduction, readers will have a clear orientation to the technical, logistical, and stakeholder forces shaping specimen collection practices. This foundation sets the stage for deeper analysis across technology modalities, sample types, end-user dynamics, disease focus areas, and distribution considerations that follow in subsequent sections.

How rapid technological advances, supply chain modernization, and regulatory alignment are reshaping specimen collection workflows and clinical testing expectations

The last several years have produced transformative shifts across the specimen collection landscape, spanning technological innovation, operational redesign, and regulatory adaptation. New assay formats and sample stabilization chemistries have reduced pre-analytical variability, enabling broader decentralization of testing. At the same time, workflow automation and digital sample tracking have tightened the link between collection and result delivery, improving traceability and shortening turnaround times. These changes have redefined expectations for specimen quality and availability.

Concurrently, the rise of rapid diagnostic modalities and the expansion of molecular sequencing have changed the kinds of specimens required and the conditions under which they must be collected and preserved. Point-of-care settings now demand collection devices that are robust, easy to use, and compatible with a range of assays. As a result, manufacturers and laboratories have prioritized user-centered design and interoperability. Regulatory bodies have also responded by clarifying guidance on biospecimen handling, which in turn has driven standardization across clinical and research environments.

Taken together, these shifts have created new opportunities and pressures: opportunities to extend testing to underserved settings and to integrate diagnostics into routine care pathways, and pressures to modernize supply chains, staff training, and quality systems to meet elevated expectations for specimen-driven decision making.

How recent tariff policy shifts have prompted strategic sourcing adaptations, supplier diversification, and operational safeguards across specimen collection supply chains

Tariff policy changes in 2025 introduced new variables into procurement strategies for specimen collection consumables, devices, and ancillary equipment. These changes influenced the sourcing calculus for diagnostic manufacturers, laboratories, and distributors by altering landed costs and shifting comparative advantages among domestic and international suppliers. In response, procurement teams reassessed supplier diversification, inventory buffering, and nearshoring options to preserve continuity of supply and maintain competitive pricing structures.

The cumulative effect on operational planning has been multifaceted. Laboratories re-evaluated their contracts to incorporate tariff-related clauses and to build flexibility into purchase orders. Manufacturers explored alternative component suppliers and, where feasible, localized assembly to mitigate exposure to variable duties. Distributors adjusted pricing frameworks and payment terms to reflect increased supply chain complexity, while also working with clients to optimize order cadence and reduce stockouts. Across the ecosystem, stakeholders emphasized scenario planning to understand how tariff volatility could affect lead times and product availability.

Importantly, these adjustments prioritized maintaining assay reliability and specimen integrity. Organizations adopted more rigorous validation protocols when transitioning between suppliers or materials and invested in supplier quality management to ensure that changes driven by tariff pressures did not compromise clinical or research outcomes. The overall response demonstrates how policy shifts can ripple across technical, commercial, and compliance dimensions of specimen collection.

Comprehensive segmentation-driven perspective on how technology modalities, specimen types, end users, disease focus, and distribution channels jointly determine operational priorities

Insightful segmentation reveals how different technologies, specimen types, end users, disease focuses, and distribution channels interact to define distinct needs and opportunities across the specimen collection domain. When analyzed by technology, immunoassays such as CLIA and ELISA present requirements for specific sample volumes and handling conditions, while PCR approaches including digital PCR and real-time PCR demand stringent nucleic acid preservation and contamination controls. Rapid tests, whether colorimetric assays or lateral flow formats, emphasize ease of collection and rapid stability, and sequencing modalities like next-generation sequencing and Sanger sequencing require high-quality nucleic acid extraction and chain-of-custody considerations.

Examining sample types shows divergent workflows for blood, swabs, tissue, and urine; swab subtypes including buccal, nasal, and throat collections each introduce distinct collection site protocols and transport media considerations, while tissue options such as formalin-fixed and fresh frozen formats require divergent preservation methods and processing timelines. End-user segmentation highlights operational contrasts among diagnostic laboratories, hospitals, point-of-care venues, and research institutes; clinical and reference laboratories demand standardized, high-throughput collection pipelines, private and public hospitals balance clinical throughput with patient comfort, clinics and field testing sites prioritize portability and simplicity, and academic or government research institutes often require specialized protocols for novel assays.

Disease-oriented segmentation draws attention to pathogen-specific nuances: hepatitis variants, HIV, influenza A and B, and SARS-CoV-2 each impose unique sampling windows, biosafety precautions, and stability concerns. Finally, distribution channel segmentation differentiates direct sales, distributor networks, and online platforms; local and national distributors influence logistics and lead times, while company websites and third-party e-commerce platforms reshape procurement behaviors and demand forecasting. Synthesizing these layers enables stakeholders to tailor product design, training, and supply strategies to the combination of technological and contextual requirements relevant to their operations.

Regional dynamics and infrastructure realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that inform tailored specimen collection strategies and investments

Regional dynamics shape both operational realities and strategic priorities for specimen collection across global health systems. In the Americas, established laboratory networks and expansive public health infrastructure emphasize high-throughput collection pathways, integration with centralized diagnostic platforms, and investment in automation that supports broad surveillance and clinical testing. North-south differences within the region encourage hybrid approaches that combine centralized capacity with mobile collection strategies to reach remote or underserved communities.

Across Europe, the Middle East and Africa, regulatory heterogeneity and variable infrastructure create a mosaic of specimen collection practices that emphasize adaptability. West European countries often focus on harmonized standards and interoperability, while parts of the Middle East and Africa prioritize capacity building, cold chain resiliency, and decentralized solutions that can operate reliably in constrained settings. These regional contrasts drive differentiated approaches to device design, staffing models, and training programs.

In Asia-Pacific, diverse healthcare ecosystems range from highly centralized laboratory systems in advanced economies to rapidly growing point-of-care networks in emerging markets. The region combines strong manufacturing capabilities with an appetite for innovation, producing both novel collection devices and scalable distribution models. Collectively, these regional characteristics influence procurement preferences, validation requirements, and the pace at which new specimen collection practices are adopted.

How market leaders combine product innovation, strategic partnerships, and supply chain resilience to establish end-to-end specimen collection solutions and customer support models

Leading companies play pivotal roles in defining product standards, driving innovation in device design, and shaping distribution channels for specimen collection. Market leaders have concentrated investments in research and development to improve sample stabilization chemistries, ergonomics of collection devices, and compatibility across assay platforms. These firms also focus on building robust quality systems and regulatory expertise to support cross-border commercialization and to accelerate adoption among clinical laboratories and point-of-care providers.

Beyond innovation, strategic partnerships and integrated service models have emerged as defining behaviors among successful companies. Collaborations with assay developers, diagnostics labs, and logistics providers enable end-to-end solutions that reduce barriers to adoption and ensure specimens arrive in a test-ready state. Additionally, companies that invest in training and customer support create meaningful differentiation by helping end users implement standardized collection protocols and minimize pre-analytical errors.

Competitive positioning is increasingly informed by supply chain resilience and the ability to offer modular solutions that meet diverse end-user needs. Firms that balance product breadth with focused investments in high-impact technologies and that offer flexible distribution options tend to capture sustained engagement from health systems, research institutes, and commercial laboratories.

Actionable strategic roadmap for industry leaders to synchronize device innovation, supply chain resilience, regulatory engagement, and customer enablement for specimen collection success

Industry leaders should adopt an integrated strategy that aligns product innovation with operational execution, regulatory foresight, and supply chain robustness. Prioritizing modular device design and compatibility across assay types will enable faster uptake in clinical and point-of-care settings and reduce validation burdens when assays or testing platforms evolve. Complementary investments in user-centric packaging, clear labeling, and training materials will improve collection fidelity and reduce pre-analytical errors, delivering better downstream outcomes.

Operationally, organizations should diversify supplier networks and consider regional manufacturing or assembly to mitigate tariff and logistics risks while maintaining quality oversight. Strengthening supplier qualification processes and implementing change control protocols will ensure that material substitutions do not degrade specimen integrity. Simultaneously, leaders must engage proactively with regulatory authorities to anticipate changes in specimen handling guidance and to streamline approvals for novel collection devices.

Finally, companies should expand collaborative models that bundle devices with training, digital sample tracking, and logistics services. By offering integrated solutions that lower the implementation burden for laboratories and clinics, organizations can accelerate adoption, create stickier customer relationships, and support public health initiatives that depend on reliable specimen collection.

A rigorous mixed-methods research approach combining stakeholder interviews, technical literature synthesis, and supplier validation to ensure reliable insights into specimen collection practices

The research methodology integrates qualitative and quantitative approaches to produce a rigorous analysis of specimen collection practices and market dynamics. Primary research includes structured interviews with laboratory directors, procurement professionals, clinicians, and device developers to capture operational insights and validation challenges. Secondary research synthesizes regulatory guidance, technical standards, and peer-reviewed literature to contextualize primary findings and to validate observed trends.

Data collection emphasized triangulation across sources to confirm consistency and to identify divergent practices by region, end user, and technology. Case studies and vendor due-diligence evaluations provided practical context for supply chain behaviors and product validation choices. In addition, thematic analysis of interview transcripts highlighted recurring pain points such as pre-analytical variability, cold chain constraints, and training gaps.

Finally, findings were subjected to internal peer review and methodological checks to ensure reliability. This included cross-referencing procedural descriptions with published technical standards and seeking clarification from subject matter experts when complex or conflicting information arose. The overall approach balances field-level nuance with systematic validation to inform practical recommendations.

Concluding synthesis emphasizing integrated specimen collection practices, cross-stakeholder collaboration, and operational priorities to sustain diagnostic reliability and public health impact

In conclusion, specimen collection lies at the center of diagnostic accuracy, research validity, and public health responsiveness. Technological advances, regulatory evolution, and regional infrastructure differences have collectively reshaped how specimens are collected, preserved, and transported. Stakeholders that align product design with end-user workflows, invest in supply chain resilience, and proactively engage with regulatory expectations will be best positioned to deliver reliable specimen-driven outcomes.

The synthesis presented here emphasizes the need for integrated solutions that reduce pre-analytical variability and support scalable testing across clinical, point-of-care, and research environments. By focusing on interoperability, training, and distribution flexibility, organizations can mitigate operational risks and enhance the impact of diagnostic and surveillance programs. The path forward requires ongoing collaboration among device makers, laboratories, healthcare providers, and policy makers to ensure specimen collection practices evolve in step with diagnostic innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of robotics-driven sample processing platforms to increase throughput and reduce contamination risk in virus specimen collection
  • 5.2. Adoption of portable point-of-care PCR analyzers for decentralized detection of influenza and SARS-CoV-2 at patient sites
  • 5.3. Implementation of telehealth-guided self-collection nasal swab kits to expand access to remote virology testing services
  • 5.4. Development of temperature-stable viral transport media formulations enabling extended shelf life and minimal cold chain reliance
  • 5.5. Emergence of dry foam swab technologies for ambient-temperature storage and transport of respiratory virus specimens in resource-limited regions
  • 5.6. Deployment of blockchain-enabled digital sample tracking systems to enhance chain-of-custody integrity and data security in virology labs
  • 5.7. Scaling up of high-throughput automated nucleic acid extraction instruments to meet surge demands during respiratory virus outbreaks
  • 5.8. Integration of multiplex molecular assay panels in routine testing protocols driving need for standardized specimen collection workflows

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Virology Specimen Collection Market, by Technology

  • 8.1. Immunoassay
    • 8.1.1. CLIA
    • 8.1.2. ELISA
  • 8.2. PCR
    • 8.2.1. Digital PCR
    • 8.2.2. Real-Time PCR
  • 8.3. Rapid Test
    • 8.3.1. Colorimetric Test
    • 8.3.2. Lateral Flow
  • 8.4. Sequencing
    • 8.4.1. Next-Generation Sequencing
    • 8.4.2. Sanger Sequencing

9. Virology Specimen Collection Market, by Sample Type

  • 9.1. Blood
  • 9.2. Swab
    • 9.2.1. Buccal Swab
    • 9.2.2. Nasal Swab
    • 9.2.3. Throat Swab
  • 9.3. Tissue
    • 9.3.1. Formalin Fixed Tissue
    • 9.3.2. Fresh Frozen Tissue
  • 9.4. Urine

10. Virology Specimen Collection Market, by End User

  • 10.1. Diagnostic Laboratories
    • 10.1.1. Clinical Laboratories
    • 10.1.2. Reference Laboratories
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Point Of Care
    • 10.3.1. Clinics
    • 10.3.2. Field Testing Sites
  • 10.4. Research Institutes
    • 10.4.1. Academic Institutes
    • 10.4.2. Government Institutes

11. Virology Specimen Collection Market, by Disease Type

  • 11.1. Hepatitis
    • 11.1.1. Hepatitis A
    • 11.1.2. Hepatitis B
    • 11.1.3. Hepatitis C
  • 11.2. HIV
  • 11.3. Influenza
    • 11.3.1. Influenza A
    • 11.3.2. Influenza B
  • 11.4. SARS-CoV-2

12. Virology Specimen Collection Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
    • 12.2.1. Local Distributors
    • 12.2.2. National Distributors
  • 12.3. Online Channels
    • 12.3.1. Company Website
    • 12.3.2. Third-Party E-Commerce

13. Virology Specimen Collection Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Virology Specimen Collection Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Virology Specimen Collection Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Becton, Dickinson and Company
    • 16.3.3. Copan Diagnostics, Inc.
    • 16.3.4. bioMerieux SA
    • 16.3.5. QIAGEN N.V.
    • 16.3.6. Puritan Medical Products Company LLC
    • 16.3.7. Sarstedt AG & Co. KG
    • 16.3.8. Greiner Bio-One International GmbH
    • 16.3.9. Merck KGaA
    • 16.3.10. Cardinal Health, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. VIROLOGY SPECIMEN COLLECTION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. VIROLOGY SPECIMEN COLLECTION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VIROLOGY SPECIMEN COLLECTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIS